+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Isothermal Nucleic Acid Amplification Technology (INAAT) - Global Market Trajectory & Analytics

  • ID: 4805655
  • Report
  • April 2021
  • Region: Global
  • 226 pages
  • Global Industry Analysts, Inc
Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market to Reach $4.3 Billion by 2027

Amid the COVID-19 crisis, the global market for Isothermal Nucleic Acid Amplification Technology (INAAT) estimated at US$2.2 Billion in the year 2020, is projected to reach a revised size of US$4.3 Billion by 2027, growing at a CAGR of 10.4% over the analysis period 2020-2027. Infectious Diseases, one of the segments analyzed in the report, is projected to record a 11.1% CAGR and reach US$2.7 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Blood Screening segment is readjusted to a revised 10.2% CAGR for the next 7-year period.

The U.S. Market is Estimated at $642.4 Million, While China is Forecast to Grow at 9.7% CAGR

The Isothermal Nucleic Acid Amplification Technology (INAAT) market in the U.S. is estimated at US$642.4 Million in the year 2020. China, the world's second largest economy, is forecast to reach a projected market size of US$745.7 Million by the year 2027 trailing a CAGR of 9.7% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 9.7% and 8.5% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 8.4% CAGR.

Research Segment to Record 7.8% CAGR

In the global Research segment, USA, Canada, Japan, China and Europe will drive the 7.9% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$243 Million in the year 2020 will reach a projected size of US$412.7 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$501.4 Million by the year 2027.

Select Competitors (Total 46 Featured):
  • Becton, Dickinson and Company
  • bioMerieux SA
  • Eiken Chemical Co., Ltd.
  • Lucigen Corporation
  • Meridian Bioscience, Inc.
  • Nugen Audio
  • Ustar Biotechnologies (Hangzhou) Ltd.
Note: Product cover images may vary from those shown

  • Influencer Market Insights
  • World Market Trajectories
  • Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market to Witness Healthy Growth, Driven by Low-cost Advantages
  • Impact of Covid-19 and a Looming Global Recession
  • Rising Incidence of HIV, Hepatitis, and Other Infectious Disease - A Key Factor Propelling the Need for INAAT
  • Exhibit 1: Global Incidence of HIV by Region: 2017
  • Rising Global Incidence of Cancer Drives the INAAT Market
  • Development of New Technologies to Propel Market Expansion
  • Microfluidic Lab-on-a-chip Technology Aids in Expanding NAAT Use to POCT
  • Global Hepatitis B Incidence and Mortality Rates
  • Active Players in United States
  • Active Players in Japan
  • Active Players in China
  • Active Players in France
  • Active Players in Germany
  • Active Players in United Kingdom
  • Total Companies Profiled: 46
Note: Product cover images may vary from those shown